STOCK TITAN

Coherus BioSciences Announces New Employment Inducement Grants

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Coherus BioSciences grants options to new employees
Positive
  • Coherus BioSciences, Inc. has granted options to purchase 48,000 shares of common stock to six newly hired employees. The exercise price is $3.84 per share, matching the closing trading price on the grant date.
Negative
  • None.

REDWOOD CITY, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective June 20, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 48,000 shares of the common stock of the Company to six newly hired employees with a per share exercise price of $3.84, the closing trading price on the grant date.

The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.

Coherus BioSciences Contact Information:

IR Contact
Marek Ciszewski
Coherus BioSciences, Inc.
IR@coherus.com


FAQ

What is the news about?

The news is about Coherus BioSciences granting options to new employees.

How many shares were granted?

48,000 shares were granted.

What is the exercise price per share?

The exercise price per share is $3.84.

When were the options granted?

The options were granted on June 20, 2023.

What is the purpose of the options?

The options were granted to induce new employees to enter into employment with the Company.

Coherus BioSciences, Inc.

NASDAQ:CHRS

CHRS Rankings

CHRS Latest News

CHRS Stock Data

85.60M
115.21M
1.39%
73.35%
25.91%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
REDWOOD CITY